stock.name

Fate Therapeutics Inc

FATE

Market Cap$737.33M
Close$

Compare Fate Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Fate Therapeutics IncFate Therapeutics Inc-4.60%-44%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$8.23

Current Fair Value

12.1% upside

Undervalued by 12.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$737.33 Million
Enterprise Value$422.16 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.64
Beta2.93
Outstanding Shares99,237,508
Avg 30 Day Volume2,807,354

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.58
PEG21.1
Price to Sales-
Price to Book Ratio2.45
Enterprise Value to Revenue6.64
Enterprise Value to EBIT-2.22
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Fate Therapeutics Inc

CEO: William Rastetter